☰

Ganesh Mani Shankar - Publications

Affiliations: 
2008 Harvard University, Cambridge, MA, United States 
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hadzipasic M, Van Beaver L, Ayinon CM, Koffie R, Winey B, Botticello T, Shankar G, Schwab JH, Oh KS, Shin JH. Postoperative Stereotactic Radiosurgery for Spinal Metastases: Clinical Outcomes, Failures, and Analysis of Local Control Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_627  0.307
2018 Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, et al. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta Neuropathologica. PMID 30123936 DOI: 10.1007/S00401-018-1899-7  0.319
2018 Sastry RA, Shankar GM, Gerstner ER, Curry WT. The impact of surgery on survival after progression of glioblastoma: A retrospective cohort analysis of a contemporary patient population. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29680441 DOI: 10.1016/J.Jocn.2018.04.004  0.31
2018 Shin JH, Shankar GM. Friday, September 28, 2018 4:05 PM–5:05 PM abstracts: tumor and deformity: 250. Safety and efficacy of fenestrated pedicle screws with cement augmentation for spinal metastases: early experience with 292 screws The Spine Journal. 18. DOI: 10.1016/J.Spinee.2018.06.515  0.304
2018 Choi B, Shankar GM, Sivaganesan A, Yanamadala V, Shin JH. Wednesday, September 26, 2018 2:00 PM – 3:00 PM Improving Quality of Life for Patients with Tumors: 82. Implication of biomarker mutations for predicting survival in patients with metastatic lung disease to the spine The Spine Journal. 18. DOI: 10.1016/J.Spinee.2018.06.093  0.334
2018 Shankar GM, Choi B, Yanamadala V, Shin JH. Wednesday, September 26, 2018 2:00 PM – 3:00 PM Improving Quality of Life for Patients with Tumors: 77. Modern targeted adjuvant therapies improves postoperative outcomes in metastatic renal cell carcinoma to the spine The Spine Journal. 18. DOI: 10.1016/J.Spinee.2018.06.088  0.316
2017 Shankar GM, Clarke MJ, Ailon T, Rhines LD, Patel SR, Sahgal A, Laufer I, Chou D, Bilsky MH, Sciubba DM, Fehlings MG, Fisher CG, Gokaslan ZL, Shin JH. The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis. Journal of Neurosurgery. Spine. 1-8. PMID 28452631 DOI: 10.3171/2016.12.Spine16995  0.312
2016 Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology. PMID 28170043 DOI: 10.1093/Neuonc/Now235  0.313
2016 Yanamadala V, Koffie RM, Shankar GM, Kumar JI, Buchlak QD, Puthenpura V, Frosch MP, Gudewicz TM, Borges LF, Shin JH. Spinal cord glioblastoma: 25years of experience from a single institution. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 26755453 DOI: 10.1016/J.Jocn.2015.11.011  0.314
2015 Shankar GM, Lelic N, Gill CM, Thorner AR, Van Hummelen P, Wisoff JH, Loeffler JS, Brastianos PK, Shin JH, Borges LF, Butler WE, Zagzag D, Brody RI, Duhaime AC, Taylor MD, et al. BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology. Acta Neuropathologica. PMID 26487540 DOI: 10.1007/S00401-015-1492-2  0.315
2014 Welzel AT, Maggio JE, Shankar GM, Walker DE, Ostaszewski BL, Li S, Klyubin I, Rowan MJ, Seubert P, Walsh DM, Selkoe DJ. Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity. Biochemistry. 53: 3908-21. PMID 24840308 DOI: 10.1021/Bi5003053  0.401
2012 Fu H, Liu B, Frost JL, Hong S, Jin M, Ostaszewski B, Shankar GM, Costantino IM, Carroll MC, Mayadas TN, Lemere CA. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia. Glia. 60: 993-1003. PMID 22438044 DOI: 10.1002/Glia.22331  0.338
2011 Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Archives of Neurology. 68: 1385-92. PMID 22084122 DOI: 10.1001/Archneurol.2011.242  0.328
2011 Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Archives of Neurology. 68: 1239-44. PMID 21987540 DOI: 10.1001/Archneurol.2011.203  0.322
2011 Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ. Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6627-38. PMID 21543591 DOI: 10.1523/Jneurosci.0203-11.2011  0.379
2011 Shankar GM, Welzel AT, McDonald JM, Selkoe DJ, Walsh DM. Isolation of low-n amyloid β-protein oligomers from cultured cells, CSF, and brain. Methods in Molecular Biology (Clifton, N.J.). 670: 33-44. PMID 20967581 DOI: 10.1007/978-1-60761-744-0_3  0.345
2010 Li S, Shankar GM, Selkoe DJ. How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity? Frontiers in Cellular Neuroscience. 4: 5. PMID 20428510 DOI: 10.3389/Fncel.2010.00005  0.32
2010 Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG, Walsh DM. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain : a Journal of Neurology. 133: 1328-41. PMID 20403962 DOI: 10.1093/Brain/Awq065  0.364
2009 Shankar GM, Walsh DM. Alzheimer's disease: synaptic dysfunction and Abeta. Molecular Neurodegeneration. 4: 48. PMID 19930651 DOI: 10.1186/1750-1326-4-48  0.429
2009 Shankar GM, Leissring MA, Adame A, Sun X, Spooner E, Masliah E, Selkoe DJ, Lemere CA, Walsh DM. Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiology of Disease. 36: 293-302. PMID 19660551 DOI: 10.1016/J.Nbd.2009.07.021  0.388
2009 Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 62: 788-801. PMID 19555648 DOI: 10.1016/J.Neuron.2009.05.012  0.415
2009 Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Archives of Neurology. 66: 190-9. PMID 19204155 DOI: 10.1001/Archneurol.2008.565  0.376
2008 Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine. 14: 837-42. PMID 18568035 DOI: 10.1038/Nm1782  0.604
2008 Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Molecular Medicine (Cambridge, Mass.). 14: 451-64. PMID 18368143 DOI: 10.2119/2007-00100.Irvine  0.343
2008 Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. O2-02-02: Soluble amyloid β-protein dimers isolated directly from Alzheimer's disease patients potently impair synaptic plasticity and memory Alzheimer's & Dementia. 4: T133-T133. DOI: 10.1016/J.Jalz.2008.05.314  0.557
2008 McDonald JM, Brayne C, Savva G, Mattews FE, Welzel A, Shankar GM, Ince PG, Selkoe DJ, Walsh DM. P3-415: The presence of Abeta dimers in soluble brain extract is associated with dementia Alzheimer's & Dementia. 4: T643-T643. DOI: 10.1016/J.Jalz.2008.05.1986  0.308
2007 Farris W, Schütz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM, Selkoe DJ. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. The American Journal of Pathology. 171: 241-51. PMID 17591969 DOI: 10.2353/Ajpath.2007.070105  0.401
2007 Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2866-75. PMID 17360908 DOI: 10.1523/Jneurosci.4970-06.2007  0.687
2006 Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. The Journal of Physiology. 572: 477-92. PMID 16469784 DOI: 10.1113/Jphysiol.2005.103754  0.424
2006 Selkoe D, Townsend M, Shankar G, Mehta T, Podlisny M, Walsh D. S1-02-04: Role of AB oligomers in AD Alzheimer's & Dementia. 2: S4-S4. DOI: 10.1016/J.Jalz.2006.05.016  0.305
2005 Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochemical Society Transactions. 33: 1087-90. PMID 16246051 DOI: 10.1042/Bst20051087  0.407
2005 Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nature Medicine. 11: 556-61. PMID 15834427 DOI: 10.1038/Nm1234  0.403
2005 Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2455-62. PMID 15758153 DOI: 10.1523/Jneurosci.4391-04.2005  0.408
2005 Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature Neuroscience. 8: 79-84. PMID 15608634 DOI: 10.1038/Nn1372  0.319
Show low-probability matches.